AbbVie to invest $380 million to expand US manufacturing in Illinois

Feb 23 (Reuters) - AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient ...

AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States

AbbVie (NYSE: ABBV) today announced a new $380 million investment to build two new active pharmaceutical ingredient (API) manufacturing facilities at its current North Chicago, Illinois, campus. These ...
Oman Observer

Building confidence in Oman’s oilfield manufacturing

MUSCAT, FEB 23As Oman advances its ambitions under Oman Vision 2040, the spotlight is increasingly shifting from mere ...

Numina Group Unveils Batchbot 2.0: AI Order Orchestration and Voice Picking for Smarter AMR Fulfillment

AI-powered RDS orchestration synchronizes AMRs and voice picking to deliver goods-to-person performance at a fraction ...
BioProcess International

AbbVie invests $380m in Chicago API manufacturing

AbbVie invests $380m in North Chicago for API manufacturing, creating 300 jobs, boosting US R&D, and expanding domestic ...

The real first step to AI-powered pharma compliance

The industry is buzzing about AI agents that could automate this work. But here’s what most companies miss: You can’t hand the keys to an AI agent when the information it needs is scattered across 20 ...
Contract Pharma

Water for Injection: Strategic Utility and the Case for Outsourcing

Learn why Water for Injection (WFI) is a strategic utility in sterile drug manufacturing and how outsourcing WFI production ...

N-TOPCon Cells Market Expands as Industry Shifts from PERC to Advanced Architectures | Valuates Reports

The global market for N-TOPCon Cells was valued at USD 10020 Million in the year 2024 and is projected to reach a revised ...